Epstein Barr virus VCA IgG ELISA Kit

ʻO ka wehewehe pōkole:

Hoʻohana ʻia ia no ka ʻike qualitative o IgG-class antibodies i ka Epstein-barr virus capsid antigen i loko o ka serum kanaka a i ʻole plasma.Manaʻo ʻia e hoʻohana ʻia i loko o nā laboratories clinical no ka hōʻoia ʻana a me ka mālama ʻana i nā maʻi e pili ana i ka maʻi me ka maʻi Epstein-barr.

Hiki i ka maʻi EBV ke alakaʻi i nā maʻi e like me X-linked lymphoid hyperplasia syndrome (XLPS), post-transplant lymphoproliferative disorder, nasopharyngeal carcinoma, Burkitt's lymphoma a me infectious mononucleosis.ʻO kahi anti-shell antigen-IgM maikaʻi, anti-shell antigen-IgG maikaʻi ʻole a me anti-EB nuclear antigen-IgG maikaʻi ʻole e hōʻike ana i kahi maʻi EBV mua;he anti-shell antigen-IgG maikaʻi a me ka anti-EB nuclear antigen-IgG hōʻike i kahi maʻi EBV hou;ʻO ka anti-shell antigen-IgG maikaʻi a me ka anti-EB nuclear antigen-IgG maikaʻi e hōʻike ana i kahi maʻi EBV mua.

ʻO ka Nasopharyngeal Carcinoma kahi maʻi maʻi maʻi e ulu ana i ka mucosa o ka nasopharynx a pili pū me ka maʻi EBV, genetics, kaiapuni a me ka meaʻai.ʻO nā hōʻailona maʻi e pili ana i ka aspiration, nasal congestion, tinnitus, lohe nalo, a me kahi ʻano occlusion i ka pepeiao.Ma waena o nā maʻi e pili ana i ka EBV, ʻike nui ʻia ka carcinoma nasopharyngeal no ka nui o ka nui a me ka nui o ka pilikia.